This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lukashevich, I. S.
Right arrow Articles by Salvato, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lukashevich, I. S.
Right arrow Articles by Salvato, M. S.
Right arrowPubmed/NCBI databases
*Gene*Genome
*Protein

 Previous Article  |  Next Article 

Journal of Virology, November 2005, p. 13934-13942, Vol. 79, No. 22
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.22.13934-13942.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses

Igor S. Lukashevich,1* Jean Patterson,2 Ricardo Carrion,2 Dmitry Moshkoff,1 Anysha Ticer,2 Juan Zapata,1 Kathleen Brasky,2 Robert Geiger,2 Gene B. Hubbard,2 Joseph Bryant,1 and Maria S. Salvato1

Institute of Human Virology, Baltimore, Maryland,1 Southwest Foundation for Biomedical Research, San Antonio, Texas2

Received 2 August 2005/ Accepted 18 August 2005

Lassa virus (LASV) and Mopeia virus (MOPV) are closely related Old World arenaviruses that can exchange genomic segments (reassort) during coinfection. Clone ML29, selected from a library of MOPV/LASV (MOP/LAS) reassortants, encodes the major antigens (nucleocapsid and glycoprotein) of LASV and the RNA polymerase and zinc-binding protein of MOPV. Replication of ML29 was attenuated in guinea pigs and nonhuman primates. In murine adoptive-transfer experiments, as little as 150 PFU of ML29 induced protective cell-mediated immunity. All strain 13 guinea pigs vaccinated with clone ML29 survived at least 70 days after LASV challenge without either disease signs or histological lesions. Rhesus macaques inoculated with clone ML29 developed primary virus-specific T cells capable of secreting gamma interferon in response to homologous MOP/LAS and heterologous MOPV and lymphocytic choriomeningitis virus. Detailed examination of two rhesus macaques infected with this MOPV/LAS reassortant revealed no histological lesions or disease signs. Thus, ML29 is a promising attenuated vaccine candidate for Lassa fever.

* Corresponding author. Mailing address: Institute of Human Virology (IHV), University of Maryland Biotechnology Institute (UMBI), 725 West Lombard Street, Baltimore, MD 21201. Phone: (410) 706-1366. Fax: (410) 706-5198. E-mail: lukashev{at}umbi.umd.edu.

Journal of Virology, November 2005, p. 13934-13942, Vol. 79, No. 22
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.22.13934-13942.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lan, S., McLay Schelde, L., Wang, J., Kumar, N., Ly, H., Liang, Y. (2009). Development of Infectious Clones for Virulent and Avirulent Pichinde Viruses: a Model Virus To Study Arenavirus-Induced Hemorrhagic Fevers. J. Virol. 83: 6357-6362 [Abstract] [Full Text]  
  • Baize, S., Marianneau, P., Loth, P., Reynard, S., Journeaux, A., Chevallier, M., Tordo, N., Deubel, V., Contamin, H. (2009). Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys. J. Virol. 83: 5890-5903 [Abstract] [Full Text]  
  • Rojek, J. M., Sanchez, A. B., Nguyen, N. T., de la Torre, J.-C., Kunz, S. (2008). Different Mechanisms of Cell Entry by Human-Pathogenic Old World and New World Arenaviruses. J. Virol. 82: 7677-7687 [Abstract] [Full Text]  
  • Chen, M., Lan, S., Ou, R., Price, G. E., Jiang, H., de la Torre, J. C., Moskophidis, D. (2008). Genomic and biological characterization of aggressive and docile strains of lymphocytic choriomeningitis virus rescued from a plasmid-based reverse-genetics system. J. Gen. Virol. 89: 1421-1433 [Abstract] [Full Text]  
  • Carrion, R. Jr., Brasky, K., Mansfield, K., Johnson, C., Gonzales, M., Ticer, A., Lukashevich, I., Tardif, S., Patterson, J. (2007). Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target Tissues. J. Virol. 81: 6482-6490 [Abstract] [Full Text]  
  • Botten, J., Alexander, J., Pasquetto, V., Sidney, J., Barrowman, P., Ting, J., Peters, B., Southwood, S., Stewart, B., Rodriguez-Carreno, M. P., Mothe, B., Whitton, J. L., Sette, A., Buchmeier, M. J. (2006). Identification of Protective Lassa Virus Epitopes That Are Restricted by HLA-A2.. J. Virol. 80: 8351-8361 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»